Similar Prostate Cancer Drugs Show Different Results in Real-World Study



(MedPage Today) — A real-world comparison of two androgen receptor pathway inhibitors (ARPIs) for advanced prostate cancer showed a significant difference in overall survival (OS).
Patients with metastatic castration-sensitive prostate cancer…



Source link : https://www.medpagetoday.com/meetingcoverage/additionalmeetings/119784

Author :

Publish date : 2026-02-07 13:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version